vs
KINGSTONE COMPANIES, INC.（KINS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是KINGSTONE COMPANIES, INC.的1.2倍（$69.8M vs $56.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 26.2%，领先357.9%），KINGSTONE COMPANIES, INC.同比增速更快（34.0% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 25.6%）
金斯顿公司总部位于纽约金斯顿，核心业务通过旗下金斯顿保险公司开展财产意外保险产品服务，同时旗下持纽约州牌照的保险保费融资公司Payments, Inc.，会与第三方持牌保费融资机构签订合作协议。在2010年专业保险代理人协会的企业绩效调查中，金斯顿保险公司在81家参评保险公司中排名第一。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KINS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$56.4M
营收增速更快
KINS
高出12.8%
21.2%
净利率更高
RIGL
高出357.9%
26.2%
两年增速更快
RIGL
近两年复合增速
25.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.4M | $69.8M |
| 净利润 | $14.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 32.7% | 33.2% |
| 净利率 | 26.2% | 384.0% |
| 营收同比 | 34.0% | 21.2% |
| 净利润同比 | 171.4% | 1769.2% |
| 每股收益（稀释后） | $1.09 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KINSRIGL
| Q4 25 | $56.4M | $69.8M | ||
| Q3 25 | $55.7M | $69.5M | ||
| Q2 25 | $52.3M | $101.7M | ||
| Q1 25 | $50.5M | $53.3M | ||
| Q4 24 | $42.1M | $57.6M | ||
| Q3 24 | $40.8M | $55.3M | ||
| Q2 24 | $36.5M | $36.8M | ||
| Q1 24 | $35.8M | $29.5M |
净利润KINSRIGL
| Q4 25 | $14.8M | $268.1M | ||
| Q3 25 | $10.9M | $27.9M | ||
| Q2 25 | $11.3M | $59.6M | ||
| Q1 25 | $3.9M | $11.4M | ||
| Q4 24 | $5.4M | $14.3M | ||
| Q3 24 | $7.0M | $12.4M | ||
| Q2 24 | $4.5M | $-1.0M | ||
| Q1 24 | $1.4M | $-8.2M |
毛利率KINSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率KINSRIGL
| Q4 25 | 32.7% | 33.2% | ||
| Q3 25 | 24.6% | 40.9% | ||
| Q2 25 | 27.1% | 60.1% | ||
| Q1 25 | 9.3% | 23.9% | ||
| Q4 24 | 15.9% | 28.9% | ||
| Q3 24 | 22.3% | 25.4% | ||
| Q2 24 | 15.7% | 1.2% | ||
| Q1 24 | 5.0% | -23.6% |
净利率KINSRIGL
| Q4 25 | 26.2% | 384.0% | ||
| Q3 25 | 19.5% | 40.2% | ||
| Q2 25 | 21.5% | 58.6% | ||
| Q1 25 | 7.7% | 21.5% | ||
| Q4 24 | 12.9% | 24.9% | ||
| Q3 24 | 17.1% | 22.5% | ||
| Q2 24 | 12.4% | -2.8% | ||
| Q1 24 | 4.0% | -27.9% |
每股收益（稀释后）KINSRIGL
| Q4 25 | $1.09 | $14.11 | ||
| Q3 25 | $0.74 | $1.46 | ||
| Q2 25 | $0.78 | $3.28 | ||
| Q1 25 | $0.27 | $0.63 | ||
| Q4 24 | $0.44 | $0.82 | ||
| Q3 24 | $0.55 | $0.70 | ||
| Q2 24 | $0.37 | $-0.06 | ||
| Q1 24 | $0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $4.4M | $52.5M |
| 股东权益账面价值 | $122.7M | $391.5M |
| 总资产 | $453.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.04× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KINSRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务KINSRIGL
| Q4 25 | $4.4M | $52.5M | ||
| Q3 25 | $4.8M | $60.0M | ||
| Q2 25 | $5.1M | $60.0M | ||
| Q1 25 | $5.4M | $60.0M | ||
| Q4 24 | $11.2M | $60.0M | ||
| Q3 24 | $17.3M | $60.0M | ||
| Q2 24 | $25.3M | $60.0M | ||
| Q1 24 | $25.3M | $60.0M |
股东权益KINSRIGL
| Q4 25 | $122.7M | $391.5M | ||
| Q3 25 | $107.7M | $117.6M | ||
| Q2 25 | $94.9M | $81.9M | ||
| Q1 25 | $82.2M | $18.6M | ||
| Q4 24 | $66.7M | $3.3M | ||
| Q3 24 | $59.7M | $-14.6M | ||
| Q2 24 | $40.8M | $-29.9M | ||
| Q1 24 | $35.7M | $-31.7M |
总资产KINSRIGL
| Q4 25 | $453.4M | $513.6M | ||
| Q3 25 | $428.6M | $242.5M | ||
| Q2 25 | $393.4M | $206.7M | ||
| Q1 25 | $385.4M | $176.0M | ||
| Q4 24 | $374.9M | $164.0M | ||
| Q3 24 | $347.0M | $139.4M | ||
| Q2 24 | $319.8M | $128.4M | ||
| Q1 24 | $318.3M | $126.5M |
负债/权益比KINSRIGL
| Q4 25 | 0.04× | 0.13× | ||
| Q3 25 | 0.04× | 0.51× | ||
| Q2 25 | 0.05× | 0.73× | ||
| Q1 25 | 0.07× | 3.23× | ||
| Q4 24 | 0.17× | 18.25× | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $73.1M | — |
| 自由现金流率自由现金流/营收 | 129.5% | — |
| 资本支出强度资本支出/营收 | 5.0% | — |
| 现金转化率经营现金流/净利润 | 5.14× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $124.0M | — |
8季度趋势，按日历期对齐
经营现金流KINSRIGL
| Q4 25 | $75.9M | $22.0M | ||
| Q3 25 | $25.9M | $24.0M | ||
| Q2 25 | $9.3M | $30.5M | ||
| Q1 25 | $17.9M | $-893.0K | ||
| Q4 24 | $57.9M | $14.5M | ||
| Q3 24 | $21.7M | $21.7M | ||
| Q2 24 | $7.1M | $302.0K | ||
| Q1 24 | $6.1M | $-5.0M |
自由现金流KINSRIGL
| Q4 25 | $73.1M | — | ||
| Q3 25 | $25.3M | — | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $17.0M | — | ||
| Q4 24 | $55.6M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率KINSRIGL
| Q4 25 | 129.5% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 33.7% | — | ||
| Q4 24 | 132.1% | — | ||
| Q3 24 | 51.6% | — | ||
| Q2 24 | 18.1% | — | ||
| Q1 24 | 15.5% | — |
资本支出强度KINSRIGL
| Q4 25 | 5.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.5% | — |
现金转化率KINSRIGL
| Q4 25 | 5.14× | 0.08× | ||
| Q3 25 | 2.38× | 0.86× | ||
| Q2 25 | 0.82× | 0.51× | ||
| Q1 25 | 4.60× | -0.08× | ||
| Q4 24 | 10.65× | 1.01× | ||
| Q3 24 | 3.12× | 1.75× | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
